{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:34Z","timestamp":1786985254804,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","award":["2022-1.2.2-T\\u00C9T-IPARI-UZ-2022-00006"],"award-info":[{"award-number":["2022-1.2.2-T\\u00C9T-IPARI-UZ-2022-00006"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","award":["NKFI-143360"],"award-info":[{"award-number":["NKFI-143360"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005909","name":"Nemzeti Fejleszt\u00e9si Miniszt\u00e9rium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009232","name":"Debreceni Egyetem","doi-asserted-by":"publisher","award":["TKP2021-EGA-18"],"award-info":[{"award-number":["TKP2021-EGA-18"]}],"id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118660","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:07:22Z","timestamp":1761077242000},"page":"118660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The role of H2S in isoproterenol-induced cardiac hypertrophy: A comparative study using slow releaser GYY4137 and a newly synthetized fast releaser BM-112"],"prefix":"10.1016","volume":"192","author":[{"given":"Alexandra","family":"Gy\u00f6ngy\u00f6si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2176-0601","authenticated-orcid":false,"given":"Simon","family":"Eskeif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1640-3295","authenticated-orcid":false,"given":"Richard","family":"Kajt\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Fenyvesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-7715","authenticated-orcid":false,"given":"Adina","family":"F\u00e9s\u00fcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Herczegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"Borb\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-7257","authenticated-orcid":false,"given":"Ilona","family":"Bereczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Lekli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2025.118660_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.biopha.2025.118660_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells12131780","article-title":"The microenvironment of the pathogenesis of cardiac hypertrophy","volume":"12","author":"Bazgir","year":"2023","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.biopha.2025.118660_bib3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118660_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4149\/gpb_2012_015","article-title":"Morphological and functional characteristics of models of experimental myocardial injury induced by isoproterenol","volume":"31","author":"Nichtova","year":"2012","journal-title":"Gen. Physiol. Biophys."},{"issue":"19","key":"10.1016\/j.biopha.2025.118660_bib5","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2174\/1381612825666190619145025","article-title":"The role of autophagy and death pathways in Dose-dependent isoproterenolinduced cardiotoxicity","volume":"25","author":"Gyongyosi","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"13","key":"10.1016\/j.biopha.2025.118660_bib6","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?","volume":"16","author":"Wang","year":"2002","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118660_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1152\/physrev.00017.2011","article-title":"Physiological implications of hydrogen sulfide: a whiff exploration that blossomed","volume":"92","author":"Wang","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118660_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuint.2016.11.016","article-title":"Reprint of: hydrogen sulfide in stroke: protective or deleterious?","volume":"107","author":"Chan","year":"2017","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.biopha.2025.118660_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/925167","article-title":"The cardioprotective effects of hydrogen sulfide in heart diseases: from molecular mechanisms to therapeutic potential","volume":"2015","author":"Shen","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2025.118660_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41420-017-0010-9","article-title":"Glucose-6-phosphate dehydrogenase is critical for suppression of cardiac hypertrophy by H(2)S","volume":"4","author":"Chhabra","year":"2018","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2025.118660_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9396089","article-title":"Exogenous hydrogen sulfide supplement attenuates Isoproterenol-Induced myocardial hypertrophy in a sirtuin 3-dependent manner","volume":"2018","author":"Zhang","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118660_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11010-016-2870-3","article-title":"Prohibitin confers cytoprotection against ISO-induced hypertrophy in H9c2 cells via attenuation of oxidative stress and modulation of Akt\/Gsk-3beta signaling","volume":"425","author":"Chowdhury","year":"2017","journal-title":"Mol. Cell Biochem."},{"issue":"9","key":"10.1016\/j.biopha.2025.118660_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184153","article-title":"E2\/ER beta inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling","volume":"12","author":"Tsai","year":"2017","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118660_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11010-013-1946-6","article-title":"GYY4137, a novel hydrogen sulfide-releasing molecule, likely protects against high glucose-induced cytotoxicity by activation of the AMPK\/mTOR signal pathway in H9c2 cells","volume":"389","author":"Wei","year":"2014","journal-title":"Mol. Cell Biochem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118660_bib15","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1039\/C8SC04683B","article-title":"Dithioesters: simple, tunable, cysteine-selective H(2)S donors","volume":"10","author":"Cerda","year":"2019","journal-title":"Chem. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2025.118660_bib16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biopha.2025.118660_bib17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41589-021-00851-1","article-title":"Bifunctional small molecules that mediate the degradation of extracellular proteins","volume":"17","author":"Caianiello","year":"2021","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118660_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020682","article-title":"STVNa attenuates Isoproterenol-Induced cardiac hypertrophy response through the HDAC4 and Prdx2\/ROS\/Trx1 pathways","volume":"21","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118660_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3858\/emm.2009.41.4.025","article-title":"Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts","volume":"41","author":"Jeong","year":"2009","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2025.118660_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065269","article-title":"BGP-15 protects against Doxorubicin-Induced cell toxicity via enhanced mitochondrial function","volume":"24","author":"Gyongyosi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118660_bib21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bbrc.2019.02.140","article-title":"Inhibited autophagy May contribute to heme toxicity in cardiomyoblast cells","volume":"511","author":"Gyongyosi","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2025.118660_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ab.2012.10.010","article-title":"Stain-free technology as a normalization tool in Western blot analysis","volume":"433","author":"Gurtler","year":"2013","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.biopha.2025.118660_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fphys.2013.00324","article-title":"Adrenergic signaling and oxidative stress: a role for sirtuins?","volume":"4","author":"Corbi","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2025.118660_bib24","article-title":"Mitochondria in pathological cardiac hypertrophy research and therapy","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118660_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ecl.2022.02.005","article-title":"Assessment of cardiovascular disease risk: a 2022 update","volume":"51","author":"Goldsborough","year":"2022","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.biopha.2025.118660_bib26","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3389\/fphar.2018.01066","article-title":"Hydrogen sulfide (H(2)S)-releasing compounds: therapeutic potential in cardiovascular diseases","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2025.118660_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cardfail.2012.04.011","article-title":"Total plasma sulfide in congestive heart failure","volume":"18","author":"Kovacic","year":"2012","journal-title":"J. Card. Fail"},{"key":"10.1016\/j.biopha.2025.118660_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1479-5876-11-130","article-title":"A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats","volume":"11","author":"Chowdhury","year":"2013","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.biopha.2025.118660_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021077","article-title":"The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2025.118660_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bbrc.2004.04.094","article-title":"Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol","volume":"318","author":"Geng","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.biopha.2025.118660_bib31","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.112.000855","article-title":"H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase","volume":"127","author":"Kondo","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2025.118660_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150137","article-title":"Up regulation of cystathione gamma lyase and hydrogen sulphide in the myocardium inhibits the progression of Isoproterenol-Caffeine induced left ventricular hypertrophy in wistar kyoto rats","volume":"11","author":"Ahmad","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118660_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/691070","article-title":"Hydrogen sulfide donor GYY4137 protects against myocardial fibrosis","volume":"2015","author":"Meng","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"issue":"4","key":"10.1016\/j.biopha.2025.118660_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1556\/APhysiol.98.2011.4.1","article-title":"The cardioprotective potential of hydrogen sulfide in myocardial ischemia\/reperfusion injury (review)","volume":"98","author":"Dongo","year":"2011","journal-title":"Acta Physiol. Hung."},{"key":"10.1016\/j.biopha.2025.118660_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6494306","article-title":"H(2)S protects against cardiac cell hypertrophy through regulation of selenoproteins","volume":"2019","author":"Greasley","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"issue":"Pt 7","key":"10.1016\/j.biopha.2025.118660_bib36","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1113\/jphysiol.2010.202838","article-title":"Mitochondrial production of reactive oxygen species contributes to the beta-adrenergic stimulation of mouse cardiomycytes","volume":"589","author":"Andersson","year":"2011","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118660_bib37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118660_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10741-012-9340-0","article-title":"Mitochondrial dysfunction in heart failure","volume":"18","author":"Rosca","year":"2013","journal-title":"Heart Fail Rev."},{"issue":"45","key":"10.1016\/j.biopha.2025.118660_bib39","doi-asserted-by":"crossref","first-page":"30901","DOI":"10.1074\/jbc.M114.602664","article-title":"Organization of the human mitochondrial hydrogen sulfide oxidation pathway","volume":"289","author":"Libiad","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2025.118660_bib40","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/acschembio.8b00463","article-title":"Cytochrome c reduction by H(2)S potentiates sulfide signaling","volume":"13","author":"Vitvitsky","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"14","key":"10.1016\/j.biopha.2025.118660_bib41","doi-asserted-by":"crossref","first-page":"22344","DOI":"10.18632\/oncotarget.15765","article-title":"Protective effect of hydrogen sulphide against myocardial hypertrophy in mice","volume":"8","author":"Shao","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biopha.2025.118660_bib42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1253\/circj.CJ-18-1065","article-title":"Autophagy in the heart","volume":"83","author":"Yamaguchi","year":"2019","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118660_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbadis.2014.05.005","article-title":"Autophagy and oxidative stress in cardiovascular diseases","volume":"1852","author":"Mei","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.biopha.2025.118660_bib44","article-title":"Autophagy in heart failure: insights into mechanisms and therapeutic implications","volume":"10","author":"Bielawska","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118660_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1074248414539564","article-title":"Toll-like receptor 4 knockout protects against isoproterenol-induced cardiac fibrosis: the role of autophagy","volume":"20","author":"Dong","year":"2015","journal-title":"J. Cardiovasc. Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118660_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.phrs.2018.03.002","article-title":"Hydrogen sulfide and autophagy: a double edged sword","volume":"131","author":"Wu","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118660_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040805","article-title":"Hypertrophy-Reduced autophagy causes cardiac dysfunction by directly impacting cardiomyocyte contractility","volume":"10","author":"Ott","year":"2021","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.biopha.2025.118660_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.380","article-title":"Exogenous H(2)S facilitating ubiquitin aggregates clearance via autophagy attenuates type 2 diabetes-induced cardiomyopathy","volume":"8","author":"Wu","year":"2017","journal-title":"Cell Death Dis."},{"issue":"23","key":"10.1016\/j.biopha.2025.118660_bib49","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.21037\/atm-20-3647","article-title":"Protective effect of hydrogen sulfide on endothelial cells through Sirt1-FoxO1-mediated autophagy","volume":"8","author":"Zhu","year":"2020","journal-title":"Ann. Transl. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:27:02Z","timestamp":1775780822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":49,"alternative-id":["S0753332225008546"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118660","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of H2S in isoproterenol-induced cardiac hypertrophy: A comparative study using slow releaser GYY4137 and a newly synthetized fast releaser BM-112","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118660"}}